Work

Discovery and Characterization of Benzamide Derivatives as Highly Potent SUCNR1 Antagonists for Cancer Immunotherapy

Year: 2026

Type: article

Source: Journal of Medicinal Chemistry

DOI: 10.1021/acs.jmedchem.5c03465

Authors: Zhiyuan Cheng, Jiacheng He, Changyao Li, Ke Quan, Limin Du, Xiaolei Chai, Xinyu Yang, Naijipu Abuduaini, Yuanyuan Fu, Jing Sun, Sen Zhang, Bo Feng, Deyan Wu, Weiwei Rui, H. Eric Xu, Linlin Yang, Mingyao Liu, Weiqiang Lu

Institutions: East China Normal University, Hainan Medical University, Shanghai Jiao Tong University, Ruijin Hospital, State Key Laboratory of Medical Genomics, State Key Laboratory of Medical Genomics, Zhengzhou University, Hainan University, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, State Key Laboratory of Drug Research

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Science and Technology Major Project

OpenAlex ID: W7160667927

FWCI:

Cites: 41

Cited by:

Related to: